Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-1|1|221|Other deterministic changes|Whole body|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-2|1|244|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-3|1|337|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-4|1|342|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-5|1|358|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-6|1|372|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-7|1|374|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-8|1|424|Other deterministic changes|Whole body|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-9|1|451|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-10|1|484|Other deterministic changes|Whole body|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-11|1|495|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-12|1|564|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-13|1|576|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-14|1|591|Other deterministic changes|Whole body|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-15|1|604|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-16|1|638|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-17|1|641|Neoplasia malignant|Lower respiratory system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-18|1|650|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-19|1|657|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology 
|3-6-1-20|1|667|Neoplasia unclassified|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 218 - neoplasm|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-21|1|667|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-22|1|670|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-23|1|682|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-24|1|687|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-25|1|703|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-26|1|704|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-27|1|713|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-28|1|718|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-29|1|723|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-30|1|730|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-31|1|737|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-32|1|752|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-33|1|765|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-34|1|773|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-35|1|802|Neoplasia malignant|Endocrine system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-36|1|807|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-37|1|822|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-38|1|828|Neoplasia malignant|Lower respiratory system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-39|1|838|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-40|1|838|Neoplasia malignant|Lower respiratory system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-41|1|857|Other deterministic changes|Whole body|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-42|1|857|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-43|1|857|Other deterministic changes|Whole body|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-44|1|861|Other deterministic changes|Whole body|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-45|1|872|Other deterministic changes|Whole body|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-46|1|874|Neoplasia malignant|Endocrine system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-47|1|876|Other deterministic changes|Whole body|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-48|1|882|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-49|1|887|Other deterministic changes|Whole body|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-50|1|912|Neoplasia benign|Endocrine system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-51|1|913|Neoplasia malignant|Lower respiratory system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-52|1|921|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 218 - neoplasm|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-53|1|922|Neoplasia malignant|Endocrine system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-54|1|923|Neoplasia malignant|Endocrine system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-55|1|923|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-56|1|923|Neoplasia malignant|Endocrine system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-57|1|923|Neoplasia malignant|Lower respiratory system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-58|1|923|Neoplasia malignant|Endocrine system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-59|1|923|Neoplasia malignant|Endocrine system|n/a|
3-6-1|Xm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-1-60|1|923|Neoplasia malignant|Endocrine system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-1|2|400|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-2|2|433|Neoplasia malignant|Lower respiratory system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-3|2|459|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-4|2|469|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-5|2|506|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-6|2|508|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-7|2|526|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-8|2|534|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-9|2|551|Neoplasia malignant|Lower respiratory system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-10|2|556|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-11|2|567|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-12|2|577|Other deterministic changes|Whole body|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-13|2|582|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-14|2|612|Neoplasia malignant|Lower respiratory system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-15|2|625|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-16|2|626|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-17|2|630|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-18|2|641|Neoplasia malignant|Endocrine system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-19|2|657|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-20|2|660|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-21|2|661|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-22|2|675|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-23|2|676|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-24|2|681|Neoplasia malignant|Lower respiratory system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-25|2|690|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-26|2|695|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-27|2|696|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-28|2|701|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-29|2|702|Other deterministic changes|Whole body|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-30|2|703|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-31|2|710|Neoplasia unclassified|Urinary system,MA: 0000380 - urinary bladder|,MPATH: 218 - neoplasm|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-32|2|713|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-33|2|725|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-34|2|730|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-35|2|731|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-36|2|733|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-37|2|734|Other deterministic changes|Whole body|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-38|2|736|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-39|2|736|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-40|2|737|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-41|2|737|Other deterministic changes|Whole body|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-42|2|741|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-43|2|744|Neoplasia malignant|Lower respiratory system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-44|2|780|Neoplasia malignant|Lower respiratory system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-45|2|792|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-46|2|799|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-47|2|811|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-48|2|814|Other deterministic changes|Whole body|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-49|2|814|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-50|2|819|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-51|2|834|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-52|2|837|Neoplasia malignant|Lower respiratory system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-53|2|845|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-54|2|846|Neoplasia benign|Lower respiratory system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-55|2|846|Neoplasia malignant|Endocrine system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-56|2|846|Other deterministic changes|Whole body|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-57|2|846|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-58|2|846|Neoplasia malignant|Lower respiratory system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-59|2|846|Neoplasia malignant|Lower respiratory system|n/a|
3-6-2|Xm-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-2-60|2|846|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-1|3|162|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-2|3|222|Neoplasia malignant|Endocrine system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-3|3|335|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-4|3|337|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-5|3|357|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-6|3|362|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-7|3|367|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-8|3|374|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-9|3|381|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-10|3|397|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-11|3|398|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-12|3|404|Neoplasia malignant|Lower respiratory system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-13|3|407|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-14|3|446|Neoplasia malignant|Endocrine system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-15|3|448|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-16|3|449|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-17|3|463|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-18|3|474|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-19|3|488|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-20|3|493|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-21|3|498|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-22|3|518|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-23|3|525|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-24|3|537|Neoplasia benign|Endocrine system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-25|3|550|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-26|3|552|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-27|3|558|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-28|3|561|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-29|3|575|Neoplasia malignant|Endocrine system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-30|3|594|Neoplasia unclassified|Nervous system and special sense organs|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-31|3|617|Neoplasia malignant|Endocrine system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-32|3|618|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-33|3|619|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-34|3|644|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-35|3|687|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-36|3|691|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-37|3|712|Neoplasia malignant|Lower respiratory system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-38|3|718|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-39|3|720|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-40|3|732|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-41|3|736|Neoplasia malignant|Lower respiratory system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-42|3|746|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-43|3|746|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-44|3|749|Neoplasia malignant|Lower respiratory system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-45|3|750|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 218 - neoplasm|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-46|3|750|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-47|3|762|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-48|3|783|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-49|3|788|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-50|3|789|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-51|3|790|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-52|3|827|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-53|3|839|Neoplasia malignant|Endocrine system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-54|3|841|Neoplasia malignant|Endocrine system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-55|3|845|Neoplasia malignant|Endocrine system|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-56|3|845|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-57|3|858|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-58|3|859|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-59|3|860|Other deterministic changes|Whole body|n/a|
3-6-3|Xm-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-3-60|3|860|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-1|4|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-2|4|196|Other deterministic changes|Whole body|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-3|4|233|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-4|4|243|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-5|4|301|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-6|4|325|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-7|4|350|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-8|4|360|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-9|4|391|Other deterministic changes|Whole body|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-10|4|416|Neoplasia malignant|Endocrine system|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-11|4|420|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-12|4|425|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-13|4|430|Neoplasia unclassified|Bone among musculo-skeletal system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-14|4|436|Other deterministic changes|Whole body|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-15|4|437|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-16|4|461|Neoplasia malignant|Lower respiratory system|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-17|4|461|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-18|4|465|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-19|4|472|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-20|4|480|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-21|4|486|Other deterministic changes|Whole body|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-22|4|488|Other deterministic changes|Whole body|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-23|4|521|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-24|4|528|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 218 - neoplasm|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-25|4|530|Other deterministic changes|Whole body|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-26|4|530|Other deterministic changes|Whole body|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-27|4|555|Other deterministic changes|Whole body|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-28|4|564|Neoplasia malignant|Lower respiratory system|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-29|4|592|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-30|4|604|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-31|4|623|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-32|4|629|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-33|4|630|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-34|4|633|Neoplasia malignant|Endocrine system|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-35|4|634|Other deterministic changes|Whole body|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-36|4|640|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-37|4|642|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-38|4|651|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-39|4|657|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-40|4|663|Neoplasia malignant|Endocrine system|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-41|4|672|Neoplasia malignant|Endocrine system|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-42|4|678|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-43|4|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-44|4|682|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-45|4|683|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-46|4|696|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-47|4|713|Neoplasia malignant|Endocrine system|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-48|4|747|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-49|4|762|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-50|4|769|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-51|4|779|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-52|4|781|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-53|4|801|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-54|4|815|Neoplasia benign|Endocrine system|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-55|4|854|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-56|4|871|Other deterministic changes|Whole body|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-57|4|873|Other deterministic changes|Whole body|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-58|4|889|Neoplasia malignant|Endocrine system|n/a|
3-6-4|Xm-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|59 (59 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-4-59|4|889|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-1|5|70|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-2|5|70|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-3|5|343|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-4|5|358|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-5|5|359|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-6|5|375|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-7|5|448|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-8|5|454|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-9|5|458|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-10|5|468|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-11|5|468|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-12|5|468|Neoplasia malignant|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-13|5|499|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-14|5|501|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-15|5|515|Neoplasia malignant|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-16|5|522|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-17|5|525|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-18|5|526|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-19|5|530|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-20|5|536|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-21|5|548|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-22|5|554|Neoplasia malignant|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-23|5|560|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-24|5|575|Neoplasia malignant|Lower respiratory system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-25|5|577|Neoplasia benign|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-26|5|583|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-27|5|591|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-28|5|592|Neoplasia unclassified|Bone among musculo-skeletal system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-29|5|595|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-30|5|602|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-31|5|602|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-32|5|606|Neoplasia malignant|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-33|5|613|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|,MPATH: 218 - neoplasm|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-34|5|616|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-35|5|623|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-36|5|624|Neoplasia benign|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-37|5|630|Neoplasia malignant|Lower respiratory system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-38|5|630|Neoplasia malignant|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-39|5|630|Neoplasia malignant|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-40|5|662|Neoplasia malignant|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-41|5|664|Neoplasia unclassified|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 218 - neoplasm|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-42|5|673|Neoplasia malignant|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-43|5|674|Neoplasia malignant|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-44|5|675|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 218 - neoplasm|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-45|5|679|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-46|5|683|Neoplasia benign|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-47|5|685|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-48|5|693|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-49|5|697|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-50|5|701|Other deterministic changes|Whole body|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-51|5|702|Neoplasia malignant|Lower respiratory system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-52|5|702|Neoplasia benign|Endocrine system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-53|5|702|Neoplasia unclassified|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 218 - neoplasm|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-54|5|715|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-55|5|725|Neoplasia benign|Lower respiratory system|n/a|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-56|5|727|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-5|Xm-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|57 (57 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-5-57|5|827|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-1|6|310|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-2|6|555|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-3|6|592|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-4|6|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-5|6|630|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-6|6|649|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-7|6|666|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-8|6|673|Neoplasia malignant|Lower respiratory system|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-9|6|712|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-10|6|725|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-11|6|740|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-12|6|743|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-13|6|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-14|6|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-15|6|768|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-16|6|799|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-17|6|803|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-18|6|824|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-19|6|891|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-20|6|908|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-21|6|909|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-22|6|912|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-23|6|950|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-24|6|981|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-25|6|982|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-26|6|985|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-27|6|986|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-28|6|987|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-29|6|988|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-30|6|991|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-31|6|993|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-32|6|994|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-33|6|995|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-34|6|998|Neoplasia malignant|Endocrine system|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-35|6|998|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-36|6|1001|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-37|6|1003|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-38|6|1004|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-39|6|1013|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-40|6|1016|Neoplasia malignant|Lower respiratory system|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-41|6|1016|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-42|6|1016|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-43|6|1016|Neoplasia malignant|Endocrine system|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-44|6|1017|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-45|6|1019|Neoplasia malignant|Lower respiratory system|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-46|6|1021|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-47|6|1027|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-48|6|1038|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-49|6|1042|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-50|6|1049|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-51|6|1061|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-52|6|1083|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-53|6|1083|Other deterministic changes|Whole body|n/a|
3-6-6|Xf-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| X-ray control|54 (54 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-6-54|6|1083|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-1|7|138|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-2|7|203|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-3|7|291|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-4|7|419|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-5|7|445|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-6|7|462|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-7|7|478|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-8|7|494|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-9|7|568|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-10|7|592|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-11|7|627|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-12|7|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-13|7|644|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-14|7|677|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-15|7|685|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-16|7|742|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-17|7|767|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-18|7|771|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-19|7|772|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-20|7|784|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-21|7|789|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-22|7|790|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-23|7|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-24|7|800|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-25|7|816|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-26|7|831|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-27|7|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-28|7|835|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-29|7|839|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-30|7|862|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-31|7|863|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-32|7|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-33|7|868|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-34|7|871|Neoplasia malignant|Endocrine system|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-35|7|889|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-36|7|909|Neoplasia unclassified|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 218 - neoplasm|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-37|7|922|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-38|7|922|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-39|7|922|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-40|7|922|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-41|7|922|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-42|7|923|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-43|7|923|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-44|7|925|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-45|7|927|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-46|7|929|Neoplasia malignant|Endocrine system|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-47|7|933|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 316 - mixed germ cell tumor|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-48|7|935|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-49|7|935|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-50|7|935|Neoplasia malignant|Endocrine system|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-51|7|936|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-52|7|939|Neoplasia malignant|Endocrine system|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-53|7|944|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-54|7|954|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-55|7|963|Other deterministic changes|Whole body|n/a|
3-6-7|Xf-3M-Gy 1,n/a|1| 92|X-rays whole body|1|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-7-56|7|993|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-1|8|166|Other deterministic changes|Whole body|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-2|8|187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-3|8|240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-4|8|292|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-5|8|334|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-6|8|335|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-7|8|350|Neoplasia malignant|Lower respiratory system|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-8|8|512|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-9|8|523|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-10|8|533|Neoplasia unclassified|Bone among musculo-skeletal system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-11|8|547|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-12|8|569|Other deterministic changes|Whole body|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-13|8|569|Other deterministic changes|Whole body|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-14|8|572|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-15|8|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-16|8|654|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-17|8|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-18|8|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-19|8|690|Other deterministic changes|Whole body|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-20|8|692|Neoplasia malignant|Endocrine system|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-21|8|694|Other deterministic changes|Whole body|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-22|8|699|Neoplasia malignant|Lower respiratory system|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-23|8|708|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-24|8|710|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-25|8|712|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-26|8|720|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-27|8|733|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-28|8|734|Neoplasia unclassified|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 218 - neoplasm|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-29|8|742|Neoplasia malignant|Endocrine system|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-30|8|764|Other deterministic changes|Whole body|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-31|8|790|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-32|8|794|Neoplasia malignant|Endocrine system|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-33|8|827|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-34|8|848|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-35|8|866|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-36|8|874|Neoplasia benign|Endocrine system|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-37|8|887|Neoplasia malignant|Endocrine system|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-38|8|887|Other deterministic changes|Whole body|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-39|8|898|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-40|8|900|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-41|8|906|Neoplasia malignant|Lower respiratory system|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-42|8|908|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-43|8|918|Neoplasia malignant|Endocrine system|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-44|8|932|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-45|8|955|Other deterministic changes|Whole body|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-46|8|964|Other deterministic changes|Whole body|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-47|8|965|Other deterministic changes|Whole body|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-48|8|966|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-49|8|966|Other deterministic changes|Whole body|n/a|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-50|8|966|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-8|Xf-3M-Gy 2,n/a|1| 92|X-rays whole body|2|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-8-51|8|966|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-1|9|163|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-2|9|224|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-3|9|236|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-4|9|246|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-5|9|251|Other deterministic changes|Whole body|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-6|9|323|Other deterministic changes|Whole body|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-7|9|327|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-8|9|348|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-9|9|384|Other deterministic changes|Whole body|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-10|9|402|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-11|9|405|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-12|9|425|Other deterministic changes|Whole body|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-13|9|426|Other deterministic changes|Whole body|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-14|9|443|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-15|9|443|Other deterministic changes|Whole body|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-16|9|467|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-17|9|475|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-18|9|484|Neoplasia malignant|Lower respiratory system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-19|9|518|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-20|9|520|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-21|9|526|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-22|9|550|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-23|9|554|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-24|9|569|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-25|9|579|Neoplasia benign|Endocrine system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-26|9|591|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-27|9|602|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-28|9|630|Neoplasia malignant|Lower respiratory system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-29|9|633|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-30|9|643|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-31|9|643|Other deterministic changes|Whole body|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-32|9|647|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-33|9|657|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-34|9|665|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-35|9|670|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-36|9|678|Neoplasia benign|Lower respiratory system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-37|9|686|Neoplasia malignant|Endocrine system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-38|9|687|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-39|9|688|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-40|9|718|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-41|9|723|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-42|9|726|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-43|9|731|Neoplasia malignant|Endocrine system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-44|9|733|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-45|9|738|Neoplasia malignant|Endocrine system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-46|9|741|Neoplasia malignant|Lower respiratory system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-47|9|743|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-48|9|753|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-49|9|758|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-50|9|758|Neoplasia malignant|Lower respiratory system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-51|9|760|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-52|9|765|Neoplasia unclassified|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 218 - neoplasm|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-53|9|770|Neoplasia malignant|Endocrine system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-54|9|783|Neoplasia malignant|Endocrine system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-55|9|795|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-56|9|801|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-57|9|827|Neoplasia malignant|Endocrine system|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-58|9|831|Other deterministic changes|Whole body|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-59|9|862|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-60|9|862|Other deterministic changes|Whole body|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-61|9|863|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-62|9|885|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-63|9|885|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-9|Xf-3M-Gy 5,n/a|1| 92|X-rays whole body|5|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|64 (64 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-9-64|9|885|Other deterministic changes|Whole body|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-1|10|266|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-2|10|280|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-3|10|290|Other deterministic changes|Whole body|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-4|10|304|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-5|10|308|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-6|10|333|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-7|10|363|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-8|10|366|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-9|10|380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-10|10|411|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-11|10|426|Other deterministic changes|Whole body|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-12|10|443|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-13|10|454|Neoplasia benign|Endocrine system|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-14|10|466|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-15|10|484|Neoplasia malignant|Endocrine system|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-16|10|488|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-17|10|488|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-18|10|492|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-19|10|502|Other deterministic changes|Whole body|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-20|10|511|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-21|10|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-22|10|530|Other deterministic changes|Whole body|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-23|10|531|Neoplasia malignant|Endocrine system|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-24|10|538|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-25|10|540|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-26|10|541|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-27|10|543|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-28|10|552|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-29|10|559|Neoplasia unclassified|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 218 - neoplasm|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-30|10|563|Other deterministic changes|Whole body|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-31|10|568|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-32|10|578|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-33|10|580|Neoplasia malignant|Endocrine system|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-34|10|585|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-35|10|588|Other deterministic changes|Whole body|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-36|10|604|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-37|10|615|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-38|10|622|Neoplasia malignant|Endocrine system|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-39|10|623|Neoplasia malignant|Lower respiratory system|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-40|10|648|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-41|10|658|Neoplasia benign|Endocrine system|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-42|10|658|Other deterministic changes|Whole body|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-43|10|663|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-44|10|678|Other deterministic changes|Whole body|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-45|10|680|Neoplasia malignant|Endocrine system|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-46|10|683|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-47|10|692|Neoplasia malignant|Endocrine system|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-48|10|697|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-49|10|698|Neoplasia benign|Endocrine system|n/a|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-50|10|726|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-10|Xf-3M-Gy 7,n/a|1| 92|X-rays whole body|7|grays|External exposure| Single exposure 250 kVp X-rays (126  mGy/min, 1.5 mm HVL)|51 (51 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-10-51|10|730|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-1|11|410|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-2|11|439|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-3|11|498|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-4|11|625|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-5|11|651|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-6|11|656|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-7|11|660|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-8|11|665|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-9|11|676|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-10|11|690|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-11|11|690|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-12|11|705|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-13|11|706|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-14|11|743|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-15|11|749|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-16|11|759|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-17|11|774|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-18|11|781|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-19|11|818|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-20|11|826|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-21|11|827|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-22|11|827|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-23|11|827|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-24|11|844|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-25|11|847|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-26|11|853|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-27|11|891|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-28|11|919|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-29|11|919|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-30|11|919|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-31|11|945|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-32|11|945|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-33|11|956|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-34|11|958|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-35|11|966|Neoplasia malignant|Lower respiratory system|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-36|11|966|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-37|11|968|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-38|11|968|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-39|11|968|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-40|11|971|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-41|11|980|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-42|11|983|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-43|11|985|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-44|11|986|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-45|11|992|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-46|11|992|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-47|11|992|Neoplasia malignant|Lower respiratory system|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-48|11|994|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-49|11|994|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-50|11|994|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-51|11|994|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-52|11|997|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-53|11|998|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-54|11|1006|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-55|11|1006|Other deterministic changes|Whole body|n/a|
3-6-11|Nm-3M-Gy 0,n/a|1| 92|none (controls)|0|grays|External exposure| Control|56 (56 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-11-56|11|1036|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-1|12|132|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-2|12|132|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-3|12|142|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-4|12|408|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-5|12|440|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-6|12|460|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-7|12|493|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-8|12|496|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-9|12|517|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-10|12|529|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-11|12|534|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-12|12|536|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-13|12|542|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-14|12|542|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-15|12|568|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-16|12|571|Neoplasia malignant|Lower respiratory system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-17|12|583|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-18|12|592|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-19|12|606|Neoplasia malignant|Lower respiratory system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-20|12|607|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-21|12|607|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-22|12|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-23|12|620|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-24|12|629|Neoplasia malignant|Lower respiratory system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-25|12|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-26|12|641|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-27|12|643|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-28|12|644|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-29|12|649|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-30|12|653|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-31|12|661|Neoplasia malignant|Lower respiratory system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-32|12|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-33|12|665|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-34|12|669|Neoplasia malignant|Lower respiratory system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-35|12|674|Neoplasia unclassified|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 218 - neoplasm|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-36|12|674|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-37|12|693|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-38|12|702|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-39|12|709|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-40|12|710|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-41|12|710|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-42|12|719|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-43|12|724|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-44|12|736|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-45|12|739|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-46|12|746|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-47|12|746|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-48|12|747|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-49|12|749|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-50|12|756|Neoplasia malignant|Lower respiratory system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-51|12|759|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-52|12|759|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-53|12|760|Neoplasia malignant|Lower respiratory system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-54|12|761|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-55|12|765|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-56|12|765|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-57|12|765|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-58|12|766|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-59|12|767|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-60|12|772|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-61|12|773|Neoplasia malignant|Lower respiratory system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-62|12|773|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-63|12|780|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-64|12|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-65|12|797|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-66|12|800|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-67|12|806|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-68|12|807|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-69|12|807|Neoplasia malignant|Endocrine system|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-70|12|807|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-71|12|807|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-72|12|808|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-73|12|809|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-74|12|812|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-75|12|812|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-76|12|818|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-77|12|819|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-78|12|819|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-79|12|821|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-80|12|821|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-81|12|823|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-82|12|823|Other deterministic changes|Whole body|n/a|
3-6-12|Nm-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|83 (83 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-12-83|12|823|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-1|13|216|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-2|13|242|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-3|13|284|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-4|13|355|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-5|13|355|Neoplasia malignant|Lower respiratory system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-6|13|443|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-7|13|446|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-8|13|461|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-9|13|501|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-10|13|517|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-11|13|524|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-12|13|537|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-13|13|541|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-14|13|546|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-15|13|559|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-16|13|580|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-17|13|583|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-18|13|606|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-19|13|608|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-20|13|615|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-21|13|627|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-22|13|640|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-23|13|643|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-24|13|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-25|13|666|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-26|13|675|Neoplasia malignant|Lower respiratory system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-27|13|687|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-28|13|691|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-29|13|695|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-30|13|701|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-31|13|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-32|13|701|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-33|13|701|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-34|13|706|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-35|13|728|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-36|13|733|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-37|13|733|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-38|13|746|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-39|13|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-40|13|770|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-41|13|771|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-42|13|774|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-43|13|774|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-44|13|774|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-45|13|777|Neoplasia malignant|Lower respiratory system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-46|13|779|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-47|13|782|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-48|13|784|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-49|13|787|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-50|13|787|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-51|13|791|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-52|13|792|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-53|13|795|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-54|13|802|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 218 - neoplasm|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-55|13|825|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-56|13|834|Neoplasia malignant|Endocrine system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-57|13|838|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-58|13|847|Neoplasia malignant|Endocrine system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-59|13|857|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-60|13|860|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-61|13|876|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-62|13|886|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-63|13|887|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-64|13|888|Neoplasia malignant|Endocrine system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-65|13|892|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-66|13|894|Neoplasia malignant|Endocrine system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-67|13|894|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-68|13|896|Neoplasia unclassified|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-69|13|896|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-70|13|896|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-71|13|897|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-72|13|897|Neoplasia benign|Endocrine system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-73|13|910|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-74|13|915|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 218 - neoplasm|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-75|13|916|Neoplasia malignant|Lower respiratory system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-76|13|917|Other deterministic changes|Whole body|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-77|13|919|Neoplasia malignant|Lower respiratory system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-78|13|922|Neoplasia benign|Endocrine system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-79|13|922|Neoplasia malignant|Endocrine system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-80|13|924|Neoplasia malignant|Endocrine system|n/a|
3-6-13|Nm-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|81 (81 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-13-81|13|926|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-1|14|222|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-2|14|223|Other deterministic changes|Whole body|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-3|14|360|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-4|14|408|Other deterministic changes|Whole body|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-5|14|442|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-6|14|474|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-7|14|477|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-8|14|481|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-9|14|481|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-10|14|534|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-11|14|534|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-12|14|547|Other deterministic changes|Whole body|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-13|14|548|Neoplasia malignant|Endocrine system|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-14|14|573|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-15|14|573|Neoplasia malignant|Endocrine system|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-16|14|582|Neoplasia malignant|Lower respiratory system|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-17|14|582|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-18|14|582|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-19|14|584|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-20|14|597|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-21|14|606|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-22|14|609|Neoplasia malignant|Endocrine system|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-23|14|639|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-24|14|639|Other deterministic changes|Whole body|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-25|14|640|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-26|14|646|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-27|14|655|Neoplasia malignant|Lower respiratory system|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-28|14|661|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-29|14|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-30|14|680|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-31|14|683|Other deterministic changes|Whole body|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-32|14|687|Neoplasia malignant|Endocrine system|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-33|14|691|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-34|14|695|Other deterministic changes|Whole body|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-35|14|696|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-36|14|698|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-37|14|717|Other deterministic changes|Whole body|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-38|14|720|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-39|14|733|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-40|14|735|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-41|14|744|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-42|14|745|Other deterministic changes|Whole body|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-43|14|746|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-44|14|748|Other deterministic changes|Whole body|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-45|14|750|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-46|14|753|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-47|14|755|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-48|14|782|Neoplasia malignant|Endocrine system|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-49|14|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-50|14|804|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-51|14|807|Other deterministic changes|Whole body|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-52|14|812|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-53|14|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-54|14|840|Other deterministic changes|Whole body|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-55|14|845|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-56|14|845|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-57|14|846|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-58|14|849|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-59|14|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-60|14|856|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-61|14|879|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-14|Nm-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|62 (62 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-14-62|14|897|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-1|15|192|Neoplasia unclassified|Central nervous system among nervous system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-2|15|247|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-3|15|249|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-4|15|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-5|15|277|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-6|15|280|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-7|15|292|Neoplasia benign|Endocrine system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-8|15|308|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-9|15|312|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-10|15|312|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-11|15|326|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-12|15|327|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-13|15|355|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-14|15|396|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-15|15|405|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-16|15|409|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-17|15|427|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-18|15|433|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-19|15|445|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-20|15|453|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-21|15|466|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-22|15|473|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-23|15|493|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-24|15|505|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-25|15|508|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-26|15|520|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-27|15|523|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-28|15|526|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-29|15|531|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-30|15|533|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-31|15|535|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-32|15|538|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-33|15|543|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-34|15|543|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-35|15|545|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-36|15|547|Neoplasia malignant|Lower respiratory system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-37|15|553|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-38|15|553|Neoplasia malignant|Lower respiratory system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-39|15|557|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-40|15|559|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-41|15|564|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-42|15|564|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-43|15|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-44|15|565|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-45|15|566|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-46|15|577|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-47|15|577|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-48|15|604|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-49|15|608|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-50|15|612|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-51|15|614|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-52|15|635|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-53|15|650|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-54|15|677|Neoplasia benign|Endocrine system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-55|15|706|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-56|15|718|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-57|15|720|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-58|15|726|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-59|15|735|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-60|15|735|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-61|15|735|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-62|15|738|Neoplasia malignant|Endocrine system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-63|15|767|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-64|15|767|Other deterministic changes|Whole body|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-65|15|769|Neoplasia benign|Endocrine system|n/a|
3-6-15|Nm-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|66 (66 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-15-66|15|786|Neoplasia malignant|Endocrine system|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-1|16|235|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-2|16|270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-3|16|291|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-4|16|303|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-5|16|305|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-6|16|308|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-7|16|314|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-8|16|314|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-9|16|337|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-10|16|348|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-11|16|353|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-12|16|361|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-13|16|363|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-14|16|368|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-15|16|417|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-16|16|439|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-17|16|450|Neoplasia malignant|Endocrine system|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-18|16|468|Neoplasia malignant|Endocrine system|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-19|16|469|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-20|16|496|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-21|16|499|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-22|16|501|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-23|16|516|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-24|16|530|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-25|16|532|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-26|16|536|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-27|16|538|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-28|16|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-29|16|552|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-30|16|557|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-31|16|561|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-32|16|569|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-33|16|611|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-34|16|619|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-35|16|649|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-36|16|658|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-37|16|658|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-38|16|659|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-39|16|659|Neoplasia malignant|Lower respiratory system|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-40|16|659|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-41|16|659|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-42|16|660|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-43|16|660|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-44|16|662|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-45|16|663|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-46|16|673|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-47|16|675|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-48|16|677|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-49|16|679|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-50|16|683|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-51|16|683|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-52|16|683|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-53|16|683|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-54|16|683|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-55|16|685|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-56|16|685|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-57|16|685|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-58|16|687|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-59|16|687|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-60|16|691|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-61|16|691|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-62|16|691|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-63|16|692|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-64|16|692|Neoplasia benign|Endocrine system|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-65|16|697|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-66|16|697|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-67|16|698|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-68|16|701|Neoplasia malignant|Lower respiratory system|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-69|16|702|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-70|16|702|Other deterministic changes|Whole body|n/a|
3-6-16|Nm-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-16-71|16|734|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-1|17|46|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-2|17|200|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-3|17|264|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-4|17|305|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-5|17|356|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-6|17|386|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-7|17|390|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-8|17|415|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-9|17|422|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-10|17|435|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-11|17|435|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-12|17|437|Neoplasia systemic|Haematolymphatic system|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-13|17|448|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-14|17|454|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-15|17|467|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-16|17|471|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-17|17|509|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-18|17|524|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-19|17|539|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-20|17|542|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-21|17|549|Neoplasia malignant|Lower respiratory system|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-22|17|572|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-23|17|576|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-24|17|581|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-25|17|582|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-26|17|584|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-27|17|589|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-28|17|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-29|17|597|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-30|17|598|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-31|17|604|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-32|17|607|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-33|17|609|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-34|17|611|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-35|17|612|Neoplasia benign|Lower respiratory system|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-36|17|622|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-37|17|623|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-38|17|627|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-39|17|627|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-40|17|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-41|17|633|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-42|17|633|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-43|17|633|Neoplasia malignant|Endocrine system|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-44|17|634|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-45|17|637|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-46|17|641|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-47|17|645|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-48|17|648|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 218 - neoplasm|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-49|17|650|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-50|17|651|Neoplasia malignant|Lower respiratory system|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-51|17|652|Neoplasia malignant|Endocrine system|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-52|17|652|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-53|17|658|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-54|17|662|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-55|17|663|Neoplasia benign|Endocrine system|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-56|17|677|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-57|17|677|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-58|17|678|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-59|17|679|Neoplasia malignant|Lower respiratory system|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-60|17|679|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-61|17|679|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-62|17|680|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-63|17|680|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-64|17|680|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-65|17|680|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-66|17|680|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-67|17|681|Neoplasia malignant|Endocrine system|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-68|17|686|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-69|17|686|Other deterministic changes|Whole body|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-70|17|688|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-17|Nm-3M-Gy 0.18,n/a|1| 92|none (controls)|0|grays|External exposure| Control|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Male|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-17-71|17|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-1|18|71|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-2|18|292|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-3|18|437|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-4|18|588|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-5|18|610|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-6|18|634|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-7|18|654|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-8|18|661|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-9|18|702|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-10|18|705|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-11|18|745|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-12|18|775|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-13|18|778|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-14|18|785|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-15|18|785|Neoplasia benign|Endocrine system|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-16|18|786|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-17|18|808|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-18|18|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-19|18|811|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-20|18|853|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-21|18|853|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-22|18|879|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-23|18|882|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-24|18|882|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-25|18|894|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-26|18|894|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-27|18|894|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-28|18|894|Neoplasia benign|Lower respiratory system|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-29|18|903|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-30|18|903|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-31|18|915|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-32|18|918|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-33|18|923|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-34|18|924|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-35|18|932|Neoplasia malignant|Lower respiratory system|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-36|18|932|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-37|18|942|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-38|18|942|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-39|18|947|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-40|18|947|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-41|18|950|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-42|18|951|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-43|18|951|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 316 - mixed germ cell tumor|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-44|18|951|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-45|18|951|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-46|18|952|Neoplasia benign|Endocrine system|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-47|18|953|Neoplasia malignant|Endocrine system|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-48|18|957|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-49|18|958|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-50|18|958|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-51|18|960|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-52|18|974|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-53|18|974|Neoplasia malignant|Endocrine system|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-54|18|980|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-55|18|990|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-56|18|999|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-57|18|1003|Other deterministic changes|Whole body|n/a|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-58|18|1004|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-59|18|1025|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-18|Nf-3M-Gy 0,n/a|1| 92|neutrons fission|0.01|grays|External exposure| Single exposure|60 (60 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-18-60|18|1026|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-1|19|117|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-2|19|239|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-3|19|290|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-4|19|363|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-5|19|437|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-6|19|534|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-7|19|584|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-8|19|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-9|19|603|Neoplasia malignant|Endocrine system|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-10|19|603|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-11|19|629|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-12|19|634|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-13|19|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-14|19|693|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-15|19|696|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-16|19|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-17|19|705|Neoplasia malignant|Lower respiratory system|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-18|19|725|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-19|19|755|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-20|19|758|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-21|19|760|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-22|19|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-23|19|793|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-24|19|803|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-25|19|809|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-26|19|814|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-27|19|827|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-28|19|831|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-29|19|832|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-30|19|835|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-31|19|836|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-32|19|836|Neoplasia benign|Lower respiratory system|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-33|19|839|Neoplasia malignant|Lower respiratory system|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-34|19|839|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-35|19|841|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-36|19|843|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-37|19|845|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-38|19|847|Neoplasia benign|Ovary among reproductive system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-39|19|847|Neoplasia benign|Endocrine system|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-40|19|849|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-41|19|857|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-42|19|860|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-43|19|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-44|19|861|Neoplasia benign|Endocrine system|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-45|19|861|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-46|19|867|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-47|19|871|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-48|19|876|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-49|19|876|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-50|19|881|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-51|19|883|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-52|19|885|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-53|19|885|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-54|19|891|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-55|19|897|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-56|19|901|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-57|19|901|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-58|19|901|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-59|19|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-60|19|913|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-61|19|919|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-62|19|920|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-63|19|924|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-64|19|926|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-65|19|929|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-66|19|929|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-67|19|933|Neoplasia benign|Endocrine system|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-68|19|933|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-69|19|944|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-70|19|956|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-71|19|959|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 218 - neoplasm|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-72|19|967|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-73|19|969|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-74|19|969|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-75|19|969|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-76|19|969|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-77|19|969|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-78|19|975|Other deterministic changes|Whole body|n/a|
3-6-19|Nf-3M-Gy 0.01,n/a|1| 92|neutrons fission|0.02|grays|External exposure| Single exposure|79 (79 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-19-79|19|1007|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-1|20|265|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-2|20|326|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-3|20|470|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-4|20|493|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-5|20|496|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-6|20|557|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-7|20|575|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-8|20|584|Neoplasia malignant|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-9|20|601|Neoplasia malignant|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-10|20|610|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-11|20|621|Neoplasia malignant|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-12|20|632|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-13|20|639|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-14|20|647|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-15|20|649|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-16|20|650|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-17|20|677|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-18|20|678|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-19|20|679|Neoplasia benign|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-20|20|685|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-21|20|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-22|20|698|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-23|20|727|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-24|20|734|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-25|20|734|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-26|20|737|Neoplasia benign|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-27|20|738|Neoplasia malignant|Lower respiratory system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-28|20|744|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-29|20|747|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-30|20|747|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-31|20|750|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-32|20|751|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-33|20|755|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-34|20|755|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-35|20|763|Neoplasia benign|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-36|20|764|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-37|20|766|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-38|20|774|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-39|20|778|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-40|20|785|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-41|20|796|Neoplasia malignant|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-42|20|796|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-43|20|799|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-44|20|801|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-45|20|805|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-46|20|811|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-47|20|812|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-48|20|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-49|20|820|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-50|20|821|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-51|20|821|Neoplasia malignant|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-52|20|824|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-53|20|825|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-54|20|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-55|20|830|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-56|20|846|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-57|20|846|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-58|20|849|Neoplasia malignant|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-59|20|849|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-60|20|849|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-61|20|853|Neoplasia malignant|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-62|20|855|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-63|20|855|Neoplasia malignant|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-64|20|857|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-65|20|870|Neoplasia malignant|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-66|20|873|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-67|20|874|Neoplasia benign|Endocrine system|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-68|20|876|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-69|20|876|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-70|20|876|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-71|20|877|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-72|20|905|Other deterministic changes|Whole body|n/a|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-73|20|909|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-74|20|941|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-20|Nf-3M-Gy 0.02,n/a|1| 92|neutrons fission|0.04|grays|External exposure| Single exposure|75 (75 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-20-75|20|946|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-1|21|53|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-2|21|231|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-3|21|300|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-4|21|364|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-5|21|383|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-6|21|393|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-7|21|407|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-8|21|432|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-9|21|472|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-10|21|483|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-11|21|514|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-12|21|515|Neoplasia malignant|Lower respiratory system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-13|21|517|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-14|21|517|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-15|21|524|Neoplasia malignant|Endocrine system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-16|21|535|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-17|21|539|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-18|21|545|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-19|21|566|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-20|21|569|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-21|21|584|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-22|21|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-23|21|605|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-24|21|622|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-25|21|624|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-26|21|627|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-27|21|670|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-28|21|671|Neoplasia malignant|Endocrine system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-29|21|675|Neoplasia malignant|Endocrine system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-30|21|718|Neoplasia malignant|Lower respiratory system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-31|21|720|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-32|21|745|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-33|21|748|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-34|21|753|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-35|21|755|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-36|21|760|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-37|21|768|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-38|21|771|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-39|21|778|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-40|21|787|Neoplasia malignant|Endocrine system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-41|21|787|Neoplasia malignant|Endocrine system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-42|21|787|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|,MPATH: 218 - neoplasm|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-43|21|788|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-44|21|793|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-45|21|796|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-46|21|796|Neoplasia malignant|Endocrine system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-47|21|796|Neoplasia malignant|Endocrine system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-48|21|799|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-49|21|801|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-50|21|809|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-51|21|812|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-52|21|836|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-53|21|837|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-54|21|845|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-55|21|848|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-56|21|852|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 218 - neoplasm|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-57|21|853|Neoplasia malignant|Endocrine system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-58|21|853|Other deterministic changes|Whole body|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-59|21|860|Neoplasia malignant|Lower respiratory system|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-60|21|872|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-21|Nf-3M-Gy 0.04,n/a|1| 92|neutrons fission|0.08|grays|External exposure| Single exposure|61 (61 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-21-61|21|888|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-1|22|260|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-2|22|328|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-3|22|331|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-4|22|343|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-5|22|348|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-6|22|348|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-7|22|355|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-8|22|387|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-9|22|403|Neoplasia malignant|Endocrine system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-10|22|404|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-11|22|439|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-12|22|456|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-13|22|482|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-14|22|507|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-15|22|517|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-16|22|523|Neoplasia malignant|Lower respiratory system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-17|22|527|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-18|22|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-19|22|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-20|22|535|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-21|22|550|Neoplasia malignant|Endocrine system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-22|22|559|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-23|22|559|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-24|22|559|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-25|22|573|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-26|22|584|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-27|22|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-28|22|602|Neoplasia malignant|Lower respiratory system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-29|22|614|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-30|22|621|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-31|22|625|Neoplasia malignant|Lower respiratory system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-32|22|630|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-33|22|635|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-34|22|636|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-35|22|645|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-36|22|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-37|22|657|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-38|22|657|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-39|22|660|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-40|22|666|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-41|22|670|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-42|22|670|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 218 - neoplasm|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-43|22|670|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-44|22|696|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-45|22|698|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-46|22|698|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-47|22|698|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-48|22|698|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-49|22|704|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-50|22|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-51|22|713|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-52|22|713|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-53|22|714|Neoplasia malignant|Endocrine system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-54|22|716|Neoplasia malignant|Endocrine system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-55|22|723|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-56|22|724|Neoplasia malignant|Endocrine system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-57|22|724|Neoplasia malignant|Endocrine system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-58|22|733|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-59|22|733|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-60|22|733|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-61|22|734|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-62|22|741|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-63|22|743|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-64|22|745|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-65|22|750|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-66|22|751|Other deterministic changes|Whole body|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-67|22|752|Neoplasia malignant|Endocrine system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-68|22|754|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-69|22|754|Neoplasia malignant|Endocrine system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-70|22|754|Neoplasia benign|Lower respiratory system|n/a|
3-6-22|Nf-3M-Gy 0.08,n/a|1| 92|neutrons fission|0.12|grays|External exposure| Single exposure|71 (71 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-22-71|22|756|Neoplasia malignant|Lower respiratory system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-1|23|40|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-2|23|44|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-3|23|140|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-4|23|262|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-5|23|288|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-6|23|288|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-7|23|341|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-8|23|363|Neoplasia benign|Lower respiratory system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-9|23|363|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-10|23|377|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-11|23|385|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|,MPATH: 218 - neoplasm|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-12|23|398|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-13|23|407|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-14|23|446|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-15|23|448|Neoplasia malignant|Lower respiratory system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-16|23|479|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-17|23|480|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-18|23|489|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-19|23|497|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-20|23|497|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-21|23|502|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-22|23|502|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-23|23|510|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|,MPATH: 218 - neoplasm|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-24|23|510|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-25|23|511|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-26|23|520|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-27|23|531|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-28|23|540|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-29|23|548|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-30|23|554|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-31|23|558|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-32|23|563|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-33|23|591|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-34|23|598|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-35|23|598|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-36|23|603|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-37|23|609|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-38|23|611|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-39|23|612|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-40|23|618|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-41|23|624|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-42|23|624|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-43|23|626|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-44|23|629|Neoplasia benign|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-45|23|631|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-46|23|646|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-47|23|649|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-48|23|650|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-49|23|650|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-50|23|650|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-51|23|650|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-52|23|651|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-53|23|657|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-54|23|668|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-55|23|669|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-56|23|669|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-57|23|679|Neoplasia benign|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-58|23|681|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-59|23|685|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-60|23|685|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-61|23|692|Neoplasia unclassified|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 218 - neoplasm|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-62|23|712|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-63|23|712|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-64|23|714|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-65|23|720|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-66|23|721|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-67|23|721|Neoplasia malignant|Lower respiratory system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-68|23|724|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-69|23|724|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-70|23|724|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-71|23|724|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-72|23|724|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-73|23|725|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-74|23|728|Other deterministic changes|Whole body|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-75|23|730|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-76|23|731|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-77|23|731|Neoplasia benign|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-78|23|734|Neoplasia unclassified|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 218 - neoplasm|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-79|23|735|Neoplasia malignant|Endocrine system|n/a|
3-6-23|Nf-3M-Gy 0.12,n/a|1| 92|neutrons fission|0.18|grays|External exposure| Single exposure|80 (80 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-23-80|23|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-1|24|154|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-2|24|155|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-3|24|167|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-4|24|172|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-5|24|191|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-6|24|191|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-7|24|260|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-8|24|269|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-9|24|279|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-10|24|315|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-11|24|332|Neoplasia malignant|Endocrine system|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-12|24|349|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-13|24|383|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-14|24|389|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-15|24|405|Neoplasia benign|Endocrine system|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-16|24|415|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-17|24|416|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-18|24|422|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-19|24|438|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-20|24|446|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-21|24|469|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-22|24|469|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-23|24|474|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-24|24|475|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-25|24|478|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-26|24|479|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-27|24|490|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-28|24|508|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-29|24|511|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-30|24|513|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-31|24|522|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-32|24|535|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-33|24|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-34|24|539|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-35|24|548|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-36|24|558|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-37|24|566|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-38|24|566|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-39|24|568|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-40|24|569|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-41|24|569|Neoplasia malignant|Endocrine system|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-42|24|576|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-43|24|578|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-44|24|578|Neoplasia malignant|Endocrine system|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-45|24|582|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-46|24|584|Neoplasia malignant|Endocrine system|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-47|24|585|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-48|24|587|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-49|24|597|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 218 - neoplasm|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-50|24|604|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-51|24|606|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-52|24|607|Neoplasia unclassified|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 218 - neoplasm|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-53|24|607|Neoplasia malignant|Lower respiratory system|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-54|24|614|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-55|24|625|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-56|24|652|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-57|24|652|Neoplasia malignant|Endocrine system|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-58|24|652|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-59|24|655|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-60|24|657|Neoplasia malignant|Endocrine system|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-61|24|681|Neoplasia malignant|Endocrine system|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-62|24|682|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-63|24|690|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-64|24|703|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-65|24|723|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-66|24|725|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-67|24|740|Neoplasia benign|Endocrine system|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-68|24|751|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-69|24|770|Neoplasia unclassified|Ovary among reproductive system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-70|24|772|Other deterministic changes|Whole body|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-71|24|774|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-72|24|783|Neoplasia malignant|Endocrine system|n/a|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-73|24|786|Neoplasia benign|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 270 - adenoma|
3-6-24|Nf-3M-Gy 0.18,n/a|n/a| n/a|n/a||n/a|n/a| n/a|74 (74 in ERA)|Mouse|Mouse, CBA/H/Cne|Female|Young Adult|Lifespan study with macroscopic/microscopic pathology|3-6-24-74|24|788|Other deterministic changes|Whole body|n/a|
		
